| US 7,507,418 B2 | ||
| Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes | ||
| Richard L. Atkinson, Mechanicsville, Va. (US); and Nikhil V. Dhurandhar, Baton Rogue, La. (US) | ||
| Assigned to Obetech, LLC, Richmond, Va. (US) | ||
| Filed on Sep. 08, 2006, as Appl. No. 11/530,289. | ||
| Claims priority of provisional application 60/715182, filed on Sep. 09, 2005. | ||
| Prior Publication US 2007/0077584 A1, Apr. 05, 2007 | ||
| Int. Cl. A61K 39/235 (2006.01); A61K 39/00 (2006.01); A61K 39/42 (2006.01); A61K 35/14 (2006.01); C12Q 1/70 (2006.01); G01N 33/53 (2006.01); A61K 39/187 (2006.01) | ||
| U.S. Cl. 424—233.1 [424/147.1; 424/159.1; 424/184.1; 424/529; 435/5; 435/7.1] | 17 Claims |
| 1. A method for predicting whether a subject infected with an obesifying adenovirus and on or about to start a regimen associated
with a change in weight and/or body fat composition may have an increased likelihood of an increased change in weight and/or
body fat composition in comparison to a subject not infected with the obesifying adenovirus, said method comprising the steps
of:
obtaining a sample from the subject on or about to start the regimen associated with a change in weight and/or body fat composition;
assaying the sample to determine whether the subject has been infected with an obesifying adenovirus that indicates an increased
likelihood of an increased change in weight and/or body fat composition; and
modifying the regimen associated with the change in weight and/or body fat composition, as needed.
|